Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. israel
  4. tumor cells
Show results for
Products
Services
Software

Companies


Refine by
Locations
Back to All Locations

  • Asia & Middle East
  • Israel
Brands

  • pluristem

Tumor Cells Equipment Supplied In Israel

4 equipment items found
In IsraelAvailable In IsraelNear Israel

Pluristem - Model PLX-Immune - Cells for Tumor Necrosis Factor Alpha (TNF-a) and Interferon-Gamma (IFN-g)

Pluristem - Model PLX-Immune - Cells for Tumor Necrosis Factor Alpha (TNF-a) and Interferon-Gamma (IFN-g)

Manufactured by:Pluristem Therapeutics Inc.   based inHaifa, ISRAEL
PLX-Immune are cells that have been induced with tumor necrosis factor alpha (TNF-a) and interferon-gamma (IFN-g), to transiently alter their secretion profile. The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in ...
CONTACT SUPPLIER

Model CYT-649 - 4 1BBL Human, His

Model CYT-649 - 4 1BBL Human, His

Manufactured by:ProSpec-Tany TechnoGene Ltd.   based inRehovot, ISRAEL
TNFSF9 Human Recombinant fused to 37 amino acids His tag at N-terminus produced in E.Coli is a single, non-glycosylated polypeptide chain containing 222 amino acids (71-254 a.a.) and having a molecular mass of 23.8 kDa. The TNFSF9 37 aa His tag fusion protein is purified by proprietary chromatographic techniques. ...
CONTACT SUPPLIER

Model CYT-149 - 4 1BBL Human

Model CYT-149 - 4 1BBL Human

Manufactured by:ProSpec-Tany TechnoGene Ltd.   based inRehovot, ISRAEL
4 1BBL Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 184 amino acids and having a molecular mass of 19.5kDa. The 4 1BBL is purified by proprietary chromatographic techniques. ...
CONTACT SUPPLIER

Model VAC2 - Immuno-Oncology for Non-Small Cell Lung Cancer (NSCLC)

Model VAC2 - Immuno-Oncology for Non-Small Cell Lung Cancer (NSCLC)

Manufactured by:Lineage Cell Therapeutics, Inc.   based inCarlsbad, CALIFORNIA (USA)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our pluripotent cell technology using a directed differentiation method, is comprised of a population ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT